ORKA· Oruka Therapeutics Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 0 | $0 |
Quarterly ownership history
Last 4 quarters
ORKA Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$3.9B
Enterprise value$2.9B
EV / EBITDA (TTM)-23.51
P/E ratio (TTM)—
Forward P/E-25.03
P/S ratio—
P/B ratio6.71
PEG ratio—
Cash Flow
Operating cash flow (TTM)-$88M
Free cash flow (TTM)-$56M
Total cash$337M
Total debt$2M
Debt / equity0.41
Current ratio22.37
Income Statement
Total revenue (TTM)—
Revenue per share (TTM)—
Gross profit (TTM)—
EBITDA (TTM)-$122M
Net income (TTM)-$84M
EPS diluted (TTM)-1.85
Shares outstanding59,856,914
Float shares41,836,325
Profitability
Gross margin0.00%
Operating margin0.00%
EBITDA margin0.00%
Net margin0.00%
Efficiency
Return on assets (TTM)-17.25%
Return on equity (TTM)-24.69%
Price History
Current price$64.59
52 Week high$91.00
52 Week low$8.91
50 day average$53.01
200 day average$31.97
Average volume (10 day)3,580,260
1-year beta—
1-year price target$142.17
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:40 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com